Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06566404
Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
Sponsor: European Institute of Oncology
View on ClinicalTrials.gov
Summary
This study aims at assessing the role of MerlinTM and ctDNA in predicting the nodal status in patients with \>pT3b melanoma, therefore candidate for adjuvant therapy regardless of sentinel lymph node status.
Official title: Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma Eligible for Lymph Node Sentinel Biopsy (CORRESPOND): an Observational Prospective Study.
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2024-10-30
Completion Date
2028-01-01
Last Updated
2024-09-23
Healthy Volunteers
No